Notice of Results

RNS Number : 7189B

Surgical Innovations Group PLC

20 April 2012

 



Surgical Innovations Group plc

("SI" or the "Company")

Notice of Results

Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of creative solutions for minimally invasive surgery ('MIS'), will announce preliminary results for the year ended 31 December 2011 on Tuesday 24 April 2012.

The management team will be hosting briefings & product demonstrations for analysts and investors on the day. If you wish to attend, or require further information, please contact Paul McManus or Fiona Henson at Walbrook PR on 020 7933 8780 or email [e-mail] or [e-mail] accordingly.

- ENDS -

Enquiries:

Surgical Innovations Group plc	www.surginno.com
Doug Liversidge, Non-Executive Chairman
Graham Bowland, Chief Executive Officer	Tel: [phone] [e-mail]
Seymour Pierce Limited	www.seymourpierce.com
Freddy Crossley / Sarah Jacobs (Corporate Finance)	Tel: [phone]
David Banks / Jacqui Briscoe (Corporate Broking)
Walbrook PR Ltd	Tel: [phone]
Paul McManus	Mob: [phone] or [e-mail]
Fiona Henson	Mob: [phone] or [e-mail]

Notes to Editors:

About Surgical Innovations Group plc

Surgical Innovations Group plc specialises in the design and manufacture of creative solutions for minimally invasive surgery (MIS) and industrial markets. 

As well as manufacturing single-use and reusable instruments for the laparoscopic market, the Group has pioneered its flagship Resposable® instrumentation combining both single use and reusable components, ensuring ongoing revenue streams and delivering the optimum procedure performance to cost ratio.

Over 120 people are employed at the Group's 32,000 square feet facility in Leeds, with in-house design, plastic injection moulding and manufacturing equipment, producing products to the highest quality standards.

The Group's patented products are sold through three main channels:

SI brand	Through an established network of distribution partners, Surgical Innovations branded products are sold in major medical markets including North America, Britain, South East Asia, Australasia and the Indian subcontinent.
OEM and IP	The Group supplies large medical device companies on an OEM basis, generating both sales and IP royalty fees.  Clients include Teleflex Medical, Olympus and CareFusion.
Industrial	SI's patented segment technology has been applied to the industrial market enabling customers to undertake inspection and maintenance of large-scale equipment, in situ with minimum disassembly and downtime.

For more information, see www.sigrouplplc.com

 

END

 

 

NORKMGMDVLKGZZM